Technology | Magnetic Resonance Imaging (MRI) | February 21, 2017

FDA Clears Compressed Sensing MRI Acceleration Technology From Siemens Healthineers

New technology employs iterative reconstruction to produce high-quality MR images at a rapid rate with zero diagnostic information loss

Siemens Healthineers, Compressed Sensing technology, MRI, FDA approval, RSNA 2017

February 21, 2017 — Siemens Healthineers announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Compressed Sensing magnetic resonance imaging (MRI) technology. Compressed Sensing slashes the long acquisition times associated with MRI to enable dramatically shortened scans. For example, cardiac cine imaging with Compressed Sensing can be completed in just 16 seconds rather than the traditional four minutes, courtesy of an algorithm that reduces the required amount of data.1

Compressed Sensing enables MR images of diagnostic quality using fewer data points. Iterative methods enable reconstruction of high-resolution MR images with no loss in information. Additionally, the efficient inline reconstruction algorithm of Compressed Sensing supports a high degree of clinical throughput. The acquired data are calculated directly at the MRI scanner, with no need to export or externally process that data.

In cardiac imaging, Compressed Sensing Cardiac Cine takes full advantage of this inline reconstruction algorithm. Rather than hold their breath 10 to 14 times over a four-minute period, patients are able to breathe freely, with images acquired in roughly 16 seconds. Motion artifacts created by breathing and heartbeats are effectively eliminated, which benefits older and critically ill patients who are unable to hold their breath.

The speed of Compressed Sensing Cardiac Cine also enables new patient groups, including those with cardiac arrhythmias, to access cardiac MRI for the first time. Where low diagnostic quality once prevented these patient subsets from realizing any benefit from cardiac MRI, the adaptive triggering of Compressed Sensing permits recording of the entire cardiac cycle – including the late diastolic phase – in real time with only one breath-hold.  Also, Compressed Sensing Cardiac Cine images can be used to accurately quantify left ventricular function.

Compressed Sensing is available on the Magnetom Aera 1.5 Telsa (1.5) and Magnetom Skyra 3T MRI scanners from Siemens Healthineers.

For more information: www.usa.siemens.com

References

1. Kido, et al. Journal of Cardiovascular Magnetic Resonance (2016).

Related Content

Siemens Healthineers Demonstrates Artificial Intelligence, Healthcare Digitalization at HIMSS19
News | Artificial Intelligence | February 13, 2019
February 13, 2019 — At the 2019 Healthcare Information and Management Systems Society (HIMSS) global conference and e
New Appropriate Use Criteria Outlined for Multimodality Imaging of Nonvalvular Heart Disease
News | Cardiac Imaging | February 11, 2019
The American College of Cardiology (ACC), along with nine other cardiology professional societies, recently published a...
Fujifilm Launches Latest Synapse 3D Version at HIMSS 2019

The new Intravoxel Incoherent Motion (IVIM) MR application in Synapse 3D

Technology | Advanced Visualization | February 08, 2019
Fujifilm Medical Systems U.S.A. will debut the latest version of its Synapse 3D solution at the Healthcare Information...
Canon Medical Debuts Alphenix 4-D CT at RSNA 2018
Technology | Angiography | February 06, 2019
Canon Medical Systems USA Inc. recently introduced a new angiography configuration featuring its Alphenix Sky + C-arm...
Canon Medical Systems Launches Alphenix Interventional Imaging Line
Technology | Angiography | February 04, 2019
Canon Medical Systems USA recently introduced its next generation of interventional systems – the Alphenix platform....
Study Assesses Risk of MRI Exams for Patients With Tattoos
News | Magnetic Resonance Imaging (MRI) | February 01, 2019
A new European study concluded that magnetic resonance imaging (MRI) exams pose little risk for people with tattoos,...
FDA Clears Perspectum's MRCP+ Digital Biliary Tree Viewer
Technology | Magnetic Resonance Imaging (MRI) | January 24, 2019
Perspectum Diagnostics received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MRCP+...
Machine Learning Uncovers New Insights Into Human Brain Through fMRI
News | Neuro Imaging | January 11, 2019
An interdisciplinary research team led by scientists from the National University of Singapore (NUS) has successfully...